Advertisement
UK markets close in 3 hours 23 minutes
  • FTSE 100

    8,088.17
    +43.36 (+0.54%)
     
  • FTSE 250

    19,802.09
    +2.37 (+0.01%)
     
  • AIM

    755.02
    +0.15 (+0.02%)
     
  • GBP/EUR

    1.1632
    +0.0004 (+0.03%)
     
  • GBP/USD

    1.2436
    -0.0016 (-0.13%)
     
  • Bitcoin GBP

    53,551.27
    +342.25 (+0.64%)
     
  • CMC Crypto 200

    1,436.27
    +12.17 (+0.85%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    83.12
    -0.24 (-0.29%)
     
  • GOLD FUTURES

    2,328.60
    -13.50 (-0.58%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,187.92
    +50.27 (+0.28%)
     
  • CAC 40

    8,138.49
    +32.71 (+0.40%)
     

GlaxoSmithKline’s Recent 3Q17 Developments

On September 27, 2017, the Japanese Ministry of Health, Labour and Welfare approved Benlysta for the treatment of systemic lupus erythematosus in patients not cured with existing therapies.